Core Competency
Announcement of the New Version of the Instruction Manual for Ruyi Zhenbao Tablets
Release time:
2024-03-16 10:17
To the broad community of medical personnel and patients:
In accordance with the contents of the “Notice of Approval for Supplementary Drug Application” issued by the National Medical Products Administration (No.: 2023B05401) for Ruyi Zhenbao Tablets, Gansu Qizheng Tibetan Medicine Co., Ltd. has revised and filed the sections on “Adverse Reactions,” “Contraindications,” and “Precautions” in the drug’s package insert. We are now releasing the new version of the package insert. If you require more detailed information or have specific questions, please feel free to contact our customer service at 400-890-1568 or call our company at 0931-5228888.
Gansu Qizheng Tibetan Medicine Co., Ltd.
March 16, 2024
Copyright Qizheng Tibetan Medicine Co., Ltd. All rights reserved. ICP Filing Number:
Internet drug information service qualification certificate number:（藏） Non-Commercial - 2018-0004 SEO